Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathy Schiffman

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II allelesLupe G Salazar, John Fikes, Scott Southwood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccinesMary L Disis, Theodore A Gooley, Kristine Rinn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccineMary L Disis, Kathy Schiffman, Katherine Guthrie, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II allelesLupe G Salazar, John Fikes, Scott Southwood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccinesMary L Disis, Theodore A Gooley, Kristine Rinn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccineMary L Disis, Kathy Schiffman, Katherine Guthrie, et al.
Pageof 2